Detalles de la búsqueda
1.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935773
2.
A Phase 2 Study of 5-Fluorouracil (5-FU), Ziv-Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients with Stage II/III Rectal Cancer.
Cancer Invest
; 35(8): 535-540, 2017 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28792245
3.
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer.
Cancer Invest
; 35(6): 386-392, 2017 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426267
4.
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.
Oncologist
; 21(3): 279-80, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26911408
5.
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
Cancer Invest
; 34(5): 213-9, 2016 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127841
6.
A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors.
Cancer Invest
; 34(6): 265-70, 2016 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27379708
7.
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer.
Invest New Drugs
; 33(1): 187-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25335932
8.
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 463-71, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25707361
9.
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors.
Cancer Invest
; 33(10): 477-82, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26460795
10.
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
J Cardiovasc Pharmacol
; 57(4): 495-504, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21297495
11.
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.
Cancer Invest
; 28(3): 275-9, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20158340
12.
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 8(7): 480-5, 498, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20864916
13.
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.
Oncologist
; 14(12): 1189-97, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19965914
14.
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
Front Oncol
; 9: 624, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355141
15.
Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
Clin Breast Cancer
; 16(5): 349-355, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27340049
16.
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.
Cancer Biol Ther
; 14(4): 340-6, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23358470
17.
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine.
Cancer Chemother Pharmacol
; 69(1): 137-44, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21626051
18.
Phase II trial of vinflunine in relapsed small cell lung cancer.
J Thorac Oncol
; 5(6): 874-8, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20521355
19.
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.
Clin Breast Cancer
; 10(5): 367-72, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20670921
20.
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
J Clin Oncol
; 28(13): 2213-9, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20351330